Veeva
Veeva sells cloud software that life sciences companies use to manage drug development and sales, so it sits among third-order compute beneficiaries: firms that gain indirectly from AI infrastructure spending through their customers' demand.
Checked against the company's own business description in its latest annual filing.
Latest disclosed
10-Q filed 2026-08-27 · period ending 2026-07-31
Pieces naming this company
None yet.
No price is shown: the Index is a map of what each company sells and where it sits, not a quote board.